US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery: market research reports

RSS Feeds

Drug Discovery market research reports and industry analysis

6  7  8  9    11    13  14  15  
Primary Biliary Cirrhosis - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Primary Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Raynauds Disease - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... therapeutic development for Raynauds Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Rhinovirus Infection - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... therapeutic development for Rhinovirus Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Sarcoidosis - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Seasonal Allergic Rhinitis - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Shigella Infections (Shigellosis) - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Shigella Infections (Shigellosis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Global Diabetic Retinopathy Market 2014-2018
6/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... Ltd., Novartis AG , Pfizer Inc., Regeneron Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc. , Abbott Laboratories Ltd., Alcon Laboratories Inc., Alimera Sciences Inc., Allergan Inc., Ampio Pharmaceuticals Inc., Antisense Therapeutics Ltd., Bausch & Lomb Inc., ...  |  read more...
USD 2,500
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
6/13/2014 | published by: Frost & Sullivan
... were conducted with leading tier 1 and tier 2 companies and industry stakeholders, such as key clinicians, the research and development (R&D) community, heads of business development, laboratory personnel and key opinion leaders. Secondary data ...  |  read more...
USD 7,500
Legionella Control (UK) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... & PROCESS TECHNOLOGIES (UK) LTD PARTNERSHIP and MSS GROUP LTD. This report covers activities such as water treatment, legionella, legionella control, water, chemicals and includes a wealth of information on the financial trends over the ...  |  read more...
USD 525
Biotechnology (Pharmaceuticals) (Global) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... DONG-E E-JIAO CO., LTD.. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Biotechnology (Pharmaceuticals) (Global) analysis is ideal for anyone wanting to: See the ...  |  read more...
USD 1,425
Global Age-Related Macular Degeneration (AMD) Market 2014-2018
6/6/2014 | published by: TechNavio - Infiniti Research Ltd.
... AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Acucela Inc., Advanced Cell Technology Inc., Alexion Pharmaceuticals Inc., Alimera Sciences Inc., Allergen Inc., Allergo Opthalmics LLC, Avalanche Biotechnologies Inc., Gilead Sciences Inc., GlaxoSmithKline plc, ...  |  read more...
USD 2,500
Global Hypercholesterolemia Market 2014-2018
6/6/2014 | published by: TechNavio - Infiniti Research Ltd.
... Inc., Pfizer Inc., Aegerion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., AtheroNova Inc., Biospherics.net Incorporated, Bristol-Myers Squibb Company, Catabasis Pharmaceuticals Inc., Cerenis Therapeutics, SA, CymaBay Therapeutics, Inc., Daiichi Sankyo Inc., Eli Lilly and Company, Esperion ...  |  read more...
USD 2,500
Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-19)
6/1/2014 | published by: Daedal Research
... World’s Top 20 disabling medical illnesses. It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of ...  |  read more...
USD 700
Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)
6/1/2014 | published by: Daedal Research
... aorta. An aneurysm can develop anywhere along aorta but it mostly occurs in the section running through abdomen (abdominal aneurysms) and chest (thoracic aneurysms). Traditionally, open surgical repair of aneurysm was the only viable treatment ...  |  read more...
USD 800
Competitor Analysis : Kallikrein Inhibitors & Bradykinin Receptor Antagonists
6/1/2014 | published by: La Merie Publishing
... prophylaxis and treatment of hereditary angioedema (HAE) as of June 2014. Inhibitors of kallikrein and antagonists of the bradykinin receptors are based on small molecules, antibodies, proteins, peptides as well as RNA and their use ...  |  read more...
USD 136
Competitor Analysis: Phosphodiesterase 4 (PDE-4) Inhibitors
6/1/2014 | published by: La Merie Publishing
... (PDE-4) as of June 2010. PDE-4 has become an attractive target for development of oral, inhaled and topical inhibitors for treatment of asthma, chronic obstructive pulmonary disease (COPD), psoriatic arthritis, psoriasis, atopic dermatitis and many ...  |  read more...
USD 272
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
6/1/2014 | published by: GBI Research
... research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs'’, which provides in-depth analysis of breast cancer therapeutics market within the eight ...  |  read more...
USD 3,500
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
6/1/2014 | published by: GBI Research
... '‘Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries'’, which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of ...  |  read more...
USD 3,500
Alzheimer's Disease Global Clinical Trials Review, H1, 2014
5/30/2014 | published by: GlobalData
... information and data relating to the clinical trials on Alzheimer’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2014
5/30/2014 | published by: GlobalData
... (Juvenile Diabetes) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 1 Diabetes (Juvenile Diabetes). It includes an overview of the trial numbers and their recruitment status ...  |  read more...
USD 2,500
Skin And Soft Tissue Infections - Pipeline Review, H1 2014
5/30/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Skin And Soft Tissue Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Ischemic Cerebral Stroke - Pipeline Review, H1 2014
5/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Ischemic Cerebral Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Type 2 Diabetes Global Clinical Trials Review, H1, 2014
5/30/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Global Choroidal Neovascularization (CNV) Market 2014-2018
5/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Affitech A/S, Allergan Inc., Chengdu Kanghong Biotech Co. Ltd., Gilead Sciences Inc., Lpath Inc., Mat Biopharma SAS, Pfizer Inc., Promedior Inc., QLT Inc., Quark Pharmaceuticals Inc., ...  |  read more...
USD 2,500
PharmaPoint: Major Depressive Disorder - Current and Future Players
5/30/2014 | published by: GlobalData
... with in-depth analysis on the companies in the rapidly growing Major Depressive Disorder Market. The report identifies and analyses the key companies shaping and driving the global Major Depressive Disorder market. The report provides insight ...  |  read more...
USD 2,995
6  7  8  9    11    13  14  15  
 
Our Clients